Non-Antibody Mediated Roles of B Cells in Allograft Survival

Current Transplantation Reports

Volumn 1, Issue 3, 2014, Pages 155-165

  Chalasani, Geetha ^a,b   Rothstein, David ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Allograft survival; Antibody independent; Antigen presentation; Effector B cells; IL 10; Regulatory B cells; TIM 1; TNF ; Transplant rejection; Transplant tolerance

Indexed keywords

EID: 84954430873     PISSN: None     EISSN: 21963029     Source Type: Journal    
DOI: 10.1007/s40472-014-0020-y     Document Type: Article

References (121)

1. Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest. 2008;118:3420–30.
2. Kissmeyer-Nielsen F, Olsen S, Petersen V, Fjeldborg O. Hyperacute rejection of kidney allografts associated with with pre-existing humoral antibodies against donor cells. Lancet. 1966;2:662–5. DOI: 10.1016/S0140-6736(66)92829-7
3. Jeannet M, Pinn VW, Flax MH, Winn HJ, Russell PS. Humoral antibodies in renal allotransplantation in man. N Engl J Med. 1970;282:111–7. DOI: 10.1056/NEJM197001152820301
4. Lachmann N et al. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation. 2009;87:1505–13. DOI: 10.1097/TP.0b013e3181a44206
5. Wiebe C et al. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant. 2012;12:1157–67. DOI: 10.1111/j.1600-6143.2012.04013.x
6. Loupy A et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med. 2013;369:1215–26. DOI: 10.1056/NEJMoa1302506
7. Janeway Jr CA, Ron J, Katz ME. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. J Immunol. 1987;138:1051–5.
8. Ron Y, Sprent J. T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. J Immunol. 1987;138:2848–56.
9. Harris DP et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol. 2000;1:475–82. DOI: 10.1038/82717
10. Dilillo DJ, Matsushita T, Tedder TF. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci. 2010;1183:38–57. DOI: 10.1111/j.1749-6632.2009.05137.x
11. Lund FE, Randall TD. Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat Rev Immunol. 2010;10:236–47. DOI: 10.1038/nri2729
12. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol. 2002;3:944–50. DOI: 10.1038/ni833
13. Wojciechowski W et al. Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus. Immunity. 2009;30:421–33. DOI: 10.1016/j.immuni.2009.01.006
14. Barr TA et al. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med. 2012;209:1001–10. This study demonstrates that IL-6 expressed by B cells is a major mediator of autoimmune disease mediated by T cells, including EAE (mice) and MS (humans). DOI: 10.1084/jem.20111675
15. Cross AH, Stark JL, Lauber J, Ramsbottom MJ, Lyons JA. Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol. 2006;180:63–70. DOI: 10.1016/j.jneuroim.2006.06.029
16. Edwards JC et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med. 2004;350:2572–81. DOI: 10.1056/NEJMoa032534
17. Bouaziz JD et al. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proc Natl Acad Sci U S A. 2007;104:20878–83. DOI: 10.1073/pnas.0709205105
18. Ding Q et al. This study indentifies TIM-1 as an inclusive marker for Bregs and as a target for Breg induction, and demonstrates that Bregs can promote tolerance in allograft models. J Clin Invest. 2011;121:3645–56. This study indentifies TIM-1 as an inclusive marker for Bregs and as a target for Breg induction, and demonstrates that Bregs can promote tolerance in allograft models. DOI: 10.1172/JCI46274
19. Fiorina P et al. Targeting CD22 reprograms B-cells and reverses autoimmune diabetes. Diabetes. 2008;57:3013–24. DOI: 10.2337/db08-0420
20. Hu CY et al. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest. 2007;117:3857–67. DOI: 10.1172/JCI32405
21. Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med. 2003;197:489–501. DOI: 10.1084/jem.20021293
22. Martin F, Kearney J. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory". Immunol Rev. 2000;175:70–9. DOI: 10.1111/j.1600-065X.2000.imr017515.x
23. Bayry J et al. Modulation of dendritic cell maturation and function by B lymphocytes. J Immunol. 2005;175:15–20. DOI: 10.4049/jimmunol.175.1.15
24. Boes M. Role of natural and immune IgM antibodies in immune responses. Mol Immunol. 2000;37:1141–9. DOI: 10.1016/S0161-5890(01)00025-6
25. Mitchison NA. T-cell-B-cell cooperation. Nat Rev Immunol. 2004;4:308–12. DOI: 10.1038/nri1334
26. Lau CM et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med. 2005;202:1171–7. DOI: 10.1084/jem.20050630
27. Rifkin IR, Leadbetter EA, Busconi L, Viglianti G, Marshak-Rothstein A. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev. 2005;204:27–42. DOI: 10.1111/j.0105-2896.2005.00239.x
28. Leadbetter EA et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 2002;416:603–7. DOI: 10.1038/416603a
29. Krieg AM et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 1995;374:546–9. DOI: 10.1038/374546a0
30. Akiba H et al. CD28-independent co-stimulation of T cells by OX40 ligand and CD70 on activated B cells. J Immunol. 1999;162:7058–65.
31. Barr TA, Brown S, Ryan G, Zhao J, Gray D. TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells. Eur J Immunol. 2007;37:3040–53. DOI: 10.1002/eji.200636483
32. Uehara S, Chase CM, Colvin RB, Russell PS, Madsen JC. Further evidence that NK cells may contribute to the development of cardiac allograft vasculopathy. Transplant Proc. 2005;37:70–1. DOI: 10.1016/j.transproceed.2005.01.052
33. Hirohashi T et al. A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am J Transplant. 2012;12:313–21. DOI: 10.1111/j.1600-6143.2011.03836.x
34. Jindra PT et al. Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts. J Immunol. 2008;180:2214–24. DOI: 10.4049/jimmunol.180.4.2214
35. Burns AM, Chong AS. Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming. J Immunol. 2011;186:214–21. DOI: 10.4049/jimmunol.1001172
36. Snider D, Segal D. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, FcγRII, and B220 molecules on murine splenic B cells. J Immunol. 1989;143:59–65.
37. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature. 1985;314:537–9. DOI: 10.1038/314537a0
38. Phan T, Grigorova I, Okada T, Cyster J. Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol. 2007;8:992–1000. DOI: 10.1038/ni1494
39. Phan TG, Green JA, Gray EE, Xu Y, Cyster JG. Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation. Nat Immunol. 2009;10:786–93. DOI: 10.1038/ni.1745
40. Kurt-Jones E et al. The role of antigen-presenting B cells in T cell priming in vivo: Studies of B cell-deficient mice. J Immunol. 1988;140:3773–8.
41. Fuchs EJ, Matzinger P. B cells turn off virgin but not memory T cells. Science. 1992;258:1156–9. DOI: 10.1126/science.1439825
42. Fu YX, Huang G, Wang Y, Chaplin DD. B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent fashion. J Exp Med. 1998;187:1009–18. DOI: 10.1084/jem.187.7.1009
43. Nolte MA et al. B cells are crucial for both development and maintenance of the splenic marginal zone. J Immunol. 2004;172:3620–7. DOI: 10.4049/jimmunol.172.6.3620
44. Ngo VN, Cornall RJ, Cyster JG. Splenic T zone development is B cell dependent. J Exp Med. 2001;194:1649–60. DOI: 10.1084/jem.194.11.1649
45. Nozaki T, Rosenblum JM, Ishii D, Tanabe K, Fairchild RL. CD4 T cell-mediated rejection of cardiac allografts in B cell-deficient mice. J Immunol. 2008;181:5257–63. DOI: 10.4049/jimmunol.181.8.5257
46. Shen H et al. A specific role for B cells in the geneartion of CD8 T cell memory by recombinant Listeria monocytogenes. J Immunol. 2003;170:1443–51. DOI: 10.4049/jimmunol.170.3.1443
47. Lund FE, Schuer K, Hollifield M, Randall TD, Garvy BA. Clearance of Pneumocystis carinii in mice is dependant on B cells but not on P.carinii-specific antibody. J Immunol. 2003;171:1423–30. DOI: 10.4049/jimmunol.171.3.1423
48. Lund F et al. B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection. J Immunol. 2006;176:6147–54. DOI: 10.4049/jimmunol.176.10.6147
49. Crawford A, MacLeod M, Schumacher T, Corlett L, Gray D. Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells. J Immunol. 2006;176:3498–506. DOI: 10.4049/jimmunol.176.6.3498
50. Barr TA, Brown S, Mastroeni P, Gray D. TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to Salmonella enterica. J Immunol. 2010;185:2783–9. DOI: 10.4049/jimmunol.1001431
51. Whitmire J et al. Requirement of B cells for generating CD4+ T cell memory. J Immunol. 2009;182:1868–76. DOI: 10.4049/jimmunol.0802501
52. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts II Importance of humoral immunity. J Immunol. 1994;152:5135–41.
53. Levesque V et al. B-cell-dependent memory T cells impede nonmyeloablative mixed chimerism induction in presensitized mice. Am J Transplant. 2011;11:2322–31. DOI: 10.1111/j.1600-6143.2011.03683.x
54. Ng Y, Oberbarnscheidt M, Chandramoorthy H, Hoffman R, Chalasani G. B cells help alloreactive T cells differentiate into memory T cells. Am J Transplant. 2010;10:1970–80. DOI: 10.1111/j.1600-6143.2010.03223.x
55. Noorchashm H et al. B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J Immunol. 2006;177:7715–22. DOI: 10.4049/jimmunol.177.11.7715
56. Zeng Q et al. B cells mediate chronic allograft rejection independently of antibody production. J Clin Invest. 2014;124:1052–6. This study establishes that secreted antibodies are not essential, and antibody-independent functions of B cells are sufficient for development of chronic rejection. Cognate and non-cognate functions of B cells contribute to chronic rejection by supporting T cell responses through antigen presentation and maintenance of lymphoid architecture. DOI: 10.1172/JCI70084
57. Kitamura D, Roes J, Kuhn R, Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature. 1991;350:423–6. DOI: 10.1038/350423a0
58. Kumazaki K et al. AID-/-mus-/- mice are agammaglobulinemic and fail to maintain B220-CD138+ plasma cells. J Immunol. 2007;178:2192–203. DOI: 10.4049/jimmunol.178.4.2192
59. O'Neill SK et al. Expression of CD80/86 on B cells is essential for autoreactive T cell activation and the development of arthritis. J Immunol. 2007;179:5109–16. DOI: 10.4049/jimmunol.179.8.5109
60. Viau M, Zouali M. B-lymphocytes, innate immunity, and autoimmunity. Clin Immunol. 2005;11:17–26. DOI: 10.1016/j.clim.2004.08.019
61. Attanavanich K, Kearney JF. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J Immunol. 2004;172:803–11. DOI: 10.4049/jimmunol.172.2.803
62. Oliver AM, Martin F, Kearney JF. IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol. 1999;162:7198–207.
63. McDonald KG, McDonough JS, Newberry RD. Adaptive immune responses are dispensable for isolated lymphoid follicle formation: antigen-naive, lymphotoxin-sufficient B lymphocytes drive the formation of mature isolated lymphoid follicles. J Immunol. 2005;174:5720–8. DOI: 10.4049/jimmunol.174.9.5720
64. Baddoura F et al. Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection. Am J Transplant. 2005;5:510–6. DOI: 10.1111/j.1600-6143.2004.00714.x
65. Nasr I et al. Tertiary lymphoid tissues generate effector and memory T cells that lead to allograft rejection. Am J Transplant. 2007;7:1071–9. DOI: 10.1111/j.1600-6143.2007.01756.x
66. Thaunat O et al. Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. Proc Natl Acad Sci U S A. 2005;102:14723–8. DOI: 10.1073/pnas.0507223102
67. Motallebzadeh R et al. Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses. FASEB J. 2012;26:51–62. DOI: 10.1096/fj.11-186973
68. Linton P et al. Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J Exp Med. 2003;197:875–83. DOI: 10.1084/jem.20021290
69. Watts TH. TNF/TNFR Family members in costimulation of T cell responses. Annu Rev Immunol. 2005;23:23–68. DOI: 10.1146/annurev.immunol.23.021704.115839
70. Xu H et al. Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Nature. 2013;496:523–7. This study identifies a novel function of non-cognate bystander B cells in providing ICOSL-mediated costimulation to TFH precursors essential for their motility into B cell follicles to compete TFH differentiation. DOI: 10.1038/nature12058
71. Weinstein JS et al. B cells in T follicular helper cell development and function: separable roles in delivery of ICOS ligand and antigen. J Immunol. 2014;192:3166–79. This study dissects the requirement of antigen presentation vs. ICOSL costimulation by B cells in TFH development and function. When cognate B cells are abundant and present specific antigens to T cells, TFH differentiation and GC responses can occur independently of ICOSL costimulation by B cells. DOI: 10.4049/jimmunol.1302617
72. Hamel KM, Cao Y, Olalekan SA, Finnegan A. B cell-specific expression of inducible costimulator ligand is necessary for the induction of arthritis in mice. Arthr Rheumatol. 2014;66:60–7. This study shows that in the absence of ICOSL on B cells, proteoglycan-induced arthritis is attenuated and GCs,TFH and IFNγ, IL-17, IL-4 and IL-21 cytokines are reduced. DOI: 10.1002/art.38207
73. Menard LC et al. B cells amplify IFN-gamma production by T cells via a TNF-alpha-mediated mechanism. J Immunol. 2007;179:4857–66. DOI: 10.4049/jimmunol.179.7.4857
74. Rauch PJ et al. Innate response activator B cells protect against microbial sepsis. Science. 2012;335:597–601. This study identifies a novel B cell population that produced GM-CSF in response to LPS and polymicrobial sepsis. GM-CSF production by B cells supports neutrophil functions in mediating bacterial clearance and reduce mortality in sepsis. DOI: 10.1126/science.1215173
75. Moulin V et al. B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med. 2000;192:475–82. DOI: 10.1084/jem.192.4.475
76. Zouggari Y et al. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med. 2013;19:1273–80. This study identifies a novel role for B cells in myocardial infarction as mediators of inflammatory monocyte recruitment into the myocardium by producing Ccl7. B cell depletion after myocardial infarction led to decreased inflammatory monocytes in myocardium, better cardiac function, and reduced systemic inflammation. DOI: 10.1038/nm.3284
77. Neta R, Salvin SB. Specific suppression of delayed hypersensitivity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity. J Immunol. 1974;113:1716–25.
78. Mizoguchi A, Mizoguchi E, Smith RN, Preffer FI, Bhan AK. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med. 1997;186:1749–56. DOI: 10.1084/jem.186.10.1749
79. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity. 2002;16:219–30. DOI: 10.1016/S1074-7613(02)00274-1
80. Wolf SD, Dittel BN, Hardardottir F, Janeway Jr CA. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med. 1996;184:2271–8. DOI: 10.1084/jem.184.6.2271
81. Evans JG et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol. 2007;178:7868–78. DOI: 10.4049/jimmunol.178.12.7868
82. Watanabe R et al. CD19 expression in B cells is important for suppression of contact hypersensitivity. Am J Pathol. 2007;171:560–70. DOI: 10.2353/ajpath.2007.061279
83. Yanaba K et al. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity. 2008;28:639–50. DOI: 10.1016/j.immuni.2008.03.017
84. Hussain S, Delovitch TL. Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner. J Immunol. 2007;179:7225–32. DOI: 10.4049/jimmunol.179.11.7225
85. Rowe V et al. Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation. Blood. 2006;108:2485–92. DOI: 10.1182/blood-2006-04-016063
86. Mauri C, Ehrenstein MR. The 'short' history of regulatory B cells. Trends Immunol. 2008;29:34–40. DOI: 10.1016/j.it.2007.10.004
87. Haas KM et al. Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J Immunol. 2010;184:4789–800. DOI: 10.4049/jimmunol.0902391
88. Brummel R, Lenert P. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides. J Immunol. 2005;174:2429–34. DOI: 10.4049/jimmunol.174.4.2429
89. Lenert P, Brummel R, Field EH, Ashman RF. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol. 2005;25:29–40. DOI: 10.1007/s10875-005-0355-6
90. Gray M, Miles K, Salter D, Gray D, Savill J. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci U S A. 2007;104:14080–5. DOI: 10.1073/pnas.0700326104
91. Blair PA et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol. 2009;182:3492–502. DOI: 10.4049/jimmunol.0803052
92. Miyazaki D, Kuo CH, Tominaga T, Inoue Y, Ono SJ. Regulatory function of CpG-activated B cells in late-phase experimental allergic conjunctivitis. Invest Ophthalmol Vis Sci. 2009;50:1626–35. DOI: 10.1167/iovs.08-2701
93. Ueno T et al. The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model. J Clin Invest. 2008;118:742–51. DOI: 10.1172/JCI32451
94. Xiao S et al. Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function. J Exp Med. 2007;204:1691–702. DOI: 10.1084/jem.20062498
95. Degauque N et al. Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice. J Clin Invest. 2008;118:735–41. DOI: 10.1172/JCI32562
96. Mann MK, Maresz K, Shriver LP, Tan Y, Dittel BN. B cell regulation of CD4 + CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J Immunol. 2007;178:3447–56. DOI: 10.4049/jimmunol.178.6.3447
97. Amu S et al. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol. 2010;125:1114–24. DOI: 10.1016/j.jaci.2010.01.018
98. Singh A et al. Regulatory role of B cells in a murine model of allergic airway disease. J Immunol. 2008;180:7318–26. DOI: 10.4049/jimmunol.180.11.7318
99. Tian J et al. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol. 2001;167:1081–9. DOI: 10.4049/jimmunol.167.2.1081
100. Carter NA, Rosser EC, Mauri C. Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis. Arthritis Res Ther. 2012;14:R32. DOI: 10.1186/ar3736
101. Moritoki Y et al. B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis. Gastroenterology. 2009;136:1037–47. DOI: 10.1053/j.gastro.2008.11.035
102. Matsushita T, Horikawa M, Iwata Y, Tedder TF. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol. 2010;185:2240–52. DOI: 10.4049/jimmunol.1001307
103. Lee KM et al. Anti-CD45RB/anti-TIM-1-induced tolerance requires regulatory B cells. Am J Transplant. 2012;12:2072–8. DOI: 10.1111/j.1600-6143.2012.04055.x
104. Miles K et al. A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells. Proc Natl Acad Sci U S A. 2012;109:887–92. This study demonstrates that apoptotic cells induce Bregs through a process that invovles the BCR and TLR-9. DOI: 10.1073/pnas.1109173109
105. Kobayashi N et al. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity. 2007;27:927–40. DOI: 10.1016/j.immuni.2007.11.011
106. Yoshizaki A et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature. 2012;491:264–8. This study demonstrates that Bregs may be expanded ex vivo for therapuetic purposes. DOI: 10.1038/nature11501
107. Gagliani N et al. Rapamycin combined with anti-CD45RB mAb and IL-10 or with G-CSF induces tolerance in a stringent mouse model of islet transplantation. PLoS One. 2011;6:e28434. DOI: 10.1371/journal.pone.0028434
108. Salvalaggio PR et al. Antigen exposure during enhanced CTLA-4 expression promotes allograft tolerance in vivo. J Immunol. 2006;176:2292–8. DOI: 10.4049/jimmunol.176.4.2292
109. Deng S et al. Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes. J Immunol. 2007;178:6028–32. DOI: 10.4049/jimmunol.178.10.6028
110. Lal G, et al. B Cell Depletion Prevents Costimulatory Blockade Induced Tolerance. (Abstract). American Journal of Transplantation 10 Supplement s4, 182 (2010).
111. Shen P et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature. 2014;507:366–70. This paper identifies plasmablasts as the major in-vivo source of IL-35, a key new "B cell" regulatory cytokine. DOI: 10.1038/nature12979
112. Bouaziz JD, Yanaba K, Tedder TF. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev. 2008;224:201–14. DOI: 10.1111/j.1600-065X.2008.00661.x
113. Thaunat O, Morelon E, Defrance T. Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis. Blood. 2010;116:515–21. DOI: 10.1182/blood-2010-01-266668
114. Clatworthy MR et al. B-cell-depleting induction therapy and acute cellular rejection. N Engl J Med. 2009;360:2683–5. DOI: 10.1056/NEJMc0808481
115. Bouaziz JD et al. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol. 2010;40:2686–91. DOI: 10.1002/eji.201040673
116. Iwata Y et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011;117:530–41. This study serves as a counterbalance to previous studies and shows that memory B cells secrete significant amounts of IL-10, and that this may be increased in autoimmune patients. DOI: 10.1182/blood-2010-07-294249
117. Blair PA et al. CD19(+)CD24(hi)CD38(hi) B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients. Immunity. 2010;32:129–40. DOI: 10.1016/j.immuni.2009.11.009
118. Newell KA et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest. 2010;120:1836–47. DOI: 10.1172/JCI39933
119. Sagoo P et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest. 2010;120:1848–61. DOI: 10.1172/JCI39922
120. Cherukuri A, et al. Immune regulation by human B cell subsets is influenced by the balance of IL-10 and TNF. J Am Soc Nephrol. In Press(2014). This study shows that human Breg activity correlates best with IL-10:TNFa ratio in transitional B cells, and that this ratio falls during rejection and may predict bad three-year outcomes.
121. Bar-Or A et al. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? Ann Neurol. 2010;67:452–61. DOI: 10.1002/ana.21939